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Background: Secundum atrial septal defect (ASD) is a common congenital heart defect in adults. Untreated, ASD leads to right ventricular (RV) 
failure, atrial arrhythmias, and pulmonary hypertension. The benefits of surgical closure in adults remain controversial. The aim of this study is to 
analyze published data on outcomes and complications of percutaneous ASD closure in adults.
Methods: PubMed searches performed for published literature on percutaneous ASD closure using the terms ASD, ASD closure or repair, and 
percutaneous or transcatheter closure.
Results: A total of 23 studies, 1958 patients, were analyzed. Baseline characteristics showed mean age of 49.1 ± 1.7 years, Qp:Qs of 2.2 ± 0.05, 
defect size 19.4 ± 1 and device size 24.0 ± 0.7. The percentage of patients in NYHA class I, II and III was 42.4 ± 6.3, 40.0 ± 6.5, and 9.3 ± 3.0 
respectively. Mean follow-up was 12.6 ± 4.9 months with a closure rate of 96.9% ± 1.4. Echocardiographic and clinical parameters are depicted in 
the table below. Complications included 1% mortality rate, 10% residual shunt, 0.8% device embolization, 5.8% new onset arrhythmias and 1.2% 
need for surgical closure.
Conclusion: Our study confirms that percutaneous ASD closure in adults with moderate pulmonary hypertension and RV dilation is safe and 
effective with reverse remodeling and better functional capacity. Prospective studies are needed to evaluate efficacy of percutaneous ASD closure in 
adults with large defects, higher shunt ratios, and severe pulmonary hypertension. 
Echocardiographic and Clinical Features at Baseline and Foillow-Up
Variables Baseline (n) Follow-Up (n) P-value
Right Atrial Volume (mL) 106.5 ± 12.6 (90) 64.2 ± 14 (87) 0.09
Left Atrial Volume (mL) 60.6 ± 11.6 (447) 58.5 ± 11.8 (444) 0.03
Right Ventricular End Diastolic Diameter (mm) 40.8 ± 1.7 (1126) 32.4 ± 1.8 (1098) < 0.0001
Right Ventricular Volume (mL) 157.2 ± 31.1 (107) 100.2 ± 22.4 (104) 0.02
Right Ventricular Ejection Fraction (%) 42.1 ± 3.8 (107) 41.3 ± 1.9 (104) 0.81
Pulmonary Artery Systolic Pressure (mmHg) 42.2 ± 2.2 (908) 34.4 ± 2.4 (793) < 0.0001
Peak VO2 (ml/kg/min) 21.5 ± 1.5 (213) 25.8 ± 2.7 (206) 0.05
NYHA I (%) 45 ± 7.5 (344) 84.1 ± 4.4 (663) 0.0013
NYHA II & III (%) 55 ± 7.5 (468) 15.9 ± 4.4 (187) 0.0013
